42 articles for FG Salituro
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.

Vertex Pharmaceuticals
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.

TBA
The Discovery of VX-745: A Novel and Selective p38a Kinase Inhibitor.

TBA
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.

Vertex Pharmaceuticals
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.

Vertex Pharmaceuticals
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.

Vertex Pharmaceuticals
Design, synthesis and molecular modeling of 3-acylamino-2- Carboxyindole NMDA receptor glycine-site antagonists

TBA
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).

Vertex Pharmaceuticals
Breakthroughs in neuroactive steroid drug discovery.

Sage Therapeutics
SAGE-718: A First-in-Class

Sage Therapeutics
Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities.

Therapeutics
Neuroactive Steroid

Sage Therapeutics
Design and synthesis of novel conformationally restricted HIV protease inhibitors.

Vertex Pharmaceuticals
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors.

Vertex Pharmaceuticals
Multisubstrate inhibition of 4-hydroxybenzoate 3-monooxygenase.

Marion Merrell Dow Research Institute
Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin.

TBA
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.

Agios Pharmaceuticals
Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.

TBA
Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statine.

TBA
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)

Sage Therapeutics
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.

Marion Merrell Dow Research Institute
COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS

TheRas
Acyl sulfonamides for treating cancer

Bayer Aktiengesellschaft
METHODS FOR TREATMENT OF CANCER

Frontier Medicines
PRMT5 INHIBITORS AND METHODS OF TREATMENT

Hangzhou Unogen Biotech
Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease

Boehringer Ingelheim International
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS

Terns Pharmaceuticals
Compounds and pharmaceutical uses thereof

SyneuRx International (Taiwan)
LRRK2 inhibitors

H. Lundbeck
Bicyclic amide compounds and methods of use thereof

Genentech
Tetrahydroisoquinoline derivatives, preparation process and use thereof

Sichuan Kelun-Biotech Biopharmaceutical
Use of aminomethylenecyclohexane-1,3-dione compound

Wigen Biomedicine Technology (Shanghai)
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer

Korea Research Institute of Chemical Technology
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Ideaya Bioscience
Substituted benzamides as RIPK2 inhibitors

Boehringer Ingelheim International
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics

Stingray Therapeutics
Amino pyrimidine compound for inhibiting protein tyrosine kinase activity

Shenzhen Targetrx
Cardiac glycoside analogs and their use in methods for inhibition of viral infection

The John Hopkins University
BTK Inhibitors

Merck Sharp & Dohme
Incontinence treatment methods

Ixaltis
Pyridinones

Boehringer Ingelheim International
Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators

Vanderbilt University